Ashley Cordova serves as Executive at NovoCure Ltd, where they oversee executive responsibilities. Since joining the company, Ashley Cordova has executed 53 insider transactions totaling $6.1M, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 27, 2021 involved exercising options for 1,465 shares valued at $218.4K.
Ashley Cordova currently holds 437,569 shares of NovoCure Ltd (NVCR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ashley Cordova has been a net seller of NVCR stock. They have purchased $996.5K and sold $5.1M worth of shares.
Ashley Cordova's most recent insider trade was on Feb 27, 2021, when they sold 1,465 shares at $149.10 per share.
Get notified when new Form 4 filings are submitted
| $117.41 |
| Discretionary |
| Sep 1, 2020 | NVCR | $0 | Award | 5,904 | $N/A | Discretionary |